Agenparl
Image default
Home » WORKSHOP ON SUPPORT FOR ORPHAN MEDICINES DEVELOPMENT

WORKSHOP ON SUPPORT FOR ORPHAN MEDICINES DEVELOPMENT

(AGENPARL) – BRUXELLES, mer 25 novembre 2020

A jar filled with pills © EU

Start date : 30/11/2020

End date : 30/11/2020

European Medicines Agency, Other bodies and agencies,

Consumer affairs and public health,

This virtual event, organised by the European Medicines Agency (EMA), aims to encourage early and efficient interactions with the regulators by highlighting pre-marketing support in medicine development in rare diseases.

The meeting will highlight and explain existing tools in the context of early product development strategy. These include:

  • orphan designation
  • protocol assistance
  • the PRIority MEdicines (PRIME) scheme.

Stakeholders have an opportunity to express their views in relation to early medicine development and regulatory interactions.

The workshop is targeted at small to medium enterprise medicine developers, academia, patients, healthcare professionals and European reference networks (ERNs), who are often at the forefront of medicine development in rare and neglected diseases.

Programme
More information on the event

0https://www.ema.europa.eu/documents/agenda/agenda-workshop-support-orphan-medicines-development_en.pdf’>https://www.ema.europa.eu/documents/agenda/agenda-workshop-support-orphan-medicines-development_en.pdf

Fonte/Source: https://europa.eu/newsroom/events/workshop-support-orphan-medicines-development_en

Post collegati

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More